Rinaldo Bellomo

Professor

Professor, Critical Care Research

EmailRinaldo.Bellomo@monash.edu

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Professor Rinaldo Bellomo AO MBBS MD FRACP FCICM FAHMS

Rinaldo Bellomo is a Professor of Intensive Care Medicine, University of Melbourne, Melbourne, Australia; Honorary Professor, Faculty of Medicine, Monash University, Melbourne Australia; Honorary Professorial Fellow, Faculty of Medicine, The University of Sydney, Sydney, Australia; Honorary Professorial Fellow, The George Institute, Sydney, Australia; Honorary Fellow, Florey Institute of Physiology, Melbourne, Australia; Honorary Professor, Faculty of Medicine, Nanjing University, Nanjing, China; and Visiting Professor, Università Vita-Salute San Raffaele, Milan, Italy. In 2018, he was awarded an Officer of the Order of Australia for distinguished service to intensive care medicine as a biomedical scientist and researcher, through infrastructure and systems development to manage the critically ill, and as an author.

Professor Bellomo is the Director of Intensive Care Research and Staff Specialist in Intensive Care at Austin Health. He is Co-Director of the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC) - a methods centre (established with a National Health and Medical Research Council (NHMRC) Enabling Grant) for investigator-initiated clinical research that supports >15 staff, >10 PhD candidates, and research programs in traumatic brain injury, sepsis, transfusion, acute lung injury, nutrition and health economics. He is a NHMRC Practitioner Fellow and was Foundation Chair of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG).

Each year for the past five years (2014-2018), Professor Bellomo has been named one of the world's most influential scientific minds of our time. Clarivate Analytics publishes "The world's most influential scientific minds" based on its analysis of data over the previous 11 years using Web of Science and InCites platforms to determine which researchers have produced work that is most frequently acknowledged by peers. Prof Bellomo is one of the researchers identified as "influencing the future direction of their field, and of the world", "on the cutting edge of their field" and "publishing work that their peers recognize as vital to the advancement of their science". He is also the recipient of a NHMRC Achievement Award and an Austin Health Distinguished Scientist Award.

In 2015, Professor Bellomo became the first ANZ biomedical researcher to have more than 1,000 papers in Scopus. He has also written more than 152 book chapters and edited 13 books in the field of intensive care medicine. As at November, in Scopus he had >1,360 papers, an h index of 112, and total lifetime citations of >68,000; and a yearly citation rate over the past 5 years of >2,500. He is the Editor-in-Chief of the journal Critical Care and Resuscitation.

Professor Bellomo has been Chief Investigator in many successful grant applications. Over the past 10 years, he has been heavily involved in the design, execution, supervision and publication of several large randomised controlled trials published in The Lancet and the New England Journal of Medicine (NEJM) for >20,000 intensive care unit (ICU) patients randomised.

Publications in PubMed

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

1 Not started
4 Active
18 Finished

Reversing Renal Medullary Hypoxia and Acute Kidney Injury in Sepsis

May, C., Lankadeva, Y. R., Bellomo, R. & Evans, R.

1/01/20 → 31/12/22

Project: Research

SPICE IV: Sedation Practice in Intensive Care Evaluation in Older ventilated Critically Ill patients; Early Sedation with Dexmedetomidine in Older Ventilated Critically Ill Patients. A Randomised Double Blind Placebo Controlled Trial - SPICE IV

Shehabi, Y., Bellomo, R., Howe, B., Hodgson, C., Presneill, J., Bailey, M., Reade, M. C., Webb, S., Campbell, L. & Seppelt, I. M.

National Health & Medical Research Council (NHMRC)

1/01/20 → 31/12/24

Project: Research

EPO-TRAUMA: ErythroPOietin alfa to prevent mortality and reduce severe disability in critically ill TRAUMA patients: a multicentre, stratified, double blind, placebo randomised controlled trial. (The EPO-TRAUMA trial)

French, C., Nichol, A., Bellomo, R., Cooper, J., Bailey, M., Higgins, L., McArthur, C., Hodgson, C., Gabbe, B., Duranteau, J., Presneill, J., Rosenfeld, J., Napolitano, L., Skrifvars, M., Reade, M. & Pettila, V.

Australian Government Department of Health

1/04/19 → 1/10/24

Project: Research

Targeted Therapeutic Mild Hypercapnia After Resuscitated Cardiac Arrest: A Phase III Multi-Centre Randomised Controlled Trial (The TAME Cardiac Arrest Trial)

Bernard, S., Eastwood, G., Bellomo, R., Stub, D., Archer, J. & Hodgson, C.

National Health & Medical Research Council (NHMRC)

1/01/17 → 31/12/21

Project: Research

SOFTER: Effect of denosumab on bone turnover markers in critically ill women - A safety and feasibility, randomised, placebo, controlled trial

Orford, N., Cooper, J., Bellomo, R., Bailey, M., Kolowicz, M., Maiden, M. & Kakho, N.

Project: Research